Stock & Company Details
Cognition Therapeutics Inc $CGTX
Price:
N/A
N/A
95M
$85M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.47
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CGTX technical indicators
Latest Cognition Therapeutics Inc (CGTX) indicator readings as of 2026-10-08.
CGTX's 14-day RSI is 38.0, in neutral territory. ADX reads 16.5, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.02, below the zero line.
Overview
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Finance Bot
Ask your questions
Start by typing a question below.
